AR101

AR101

2018

Efficacy and Safety of AR101 in Peanut Allergy: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Presented at the AAAAI/WAO Joint Congress, March 2018.

AR101Presentation

2017

Current Management and Use of Oral Immunotherapy for Peanut Allergy Across Western Europe posters

Presented at the EAACI Pediatric Allergy and Asthma Meeting, October 2017.

AR101Poster

2016

2015

Back to top